| Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line K Zandi, E Ramedani, K Mohammadi, S Tajbakhsh, I Deilami, Z Rastian, ... Natural product communications 5 (12), 1934578X1000501220, 2010 | 71 | 2010 |
| In vitro antitumor activity of Gracilaria corticata (a red alga) against Jurkat and molt-4 human cancer cell lines K Zandi, S Tajbakhsh, I Nabipour, Z Rastian, F Yousefi, S Sharafian, ... African Journal of Biotechnology 9 (40), 6787-6790, 2010 | 70 | 2010 |
| The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran B Bazzaz, M Naderinasab, A Mohamadpoor, Z Farshadzadeh, S Ahmadi, ... Acta microbiologica et immunologica Hungarica 56 (1), 89-99, 2009 | 55 | 2009 |
| Anticancer activity of Sargassum oligocystum water extract against human cancer cell lines K Zandi, S Ahmadzadeh, S Tajbakhsh, Z Rastian, F Yousefi, ... European review for medical and pharmacological sciences 14, 669-673, 2010 | 50 | 2010 |
| Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy F Yousefi, SD Siadat, AA Saraji, S Hesaraki, MM Aslani, SF Mousavi, ... Tumor Biology 37 (4), 5305-5316, 2016 | 8 | 2016 |
| In silico design and analysis of TGFαl3-seb fusion protein as “a new antitumor agent” candidate by ligand-targeted superantigens technique AA Imani-Fooladi, F Yousefi, SF Mousavi, J Amani Iranian journal of cancer prevention 7 (3), 152, 2014 | 8 | 2014 |
| Preparation and in vitro evaluation of antitumor activity of tgfαl3-seb as a ligand-targeted superantigen F Yousefi, SF Mousavi, SD Siadat, MM Aslani, J Amani, HS Rad, ... Technology in cancer research & treatment 15 (2), 215-226, 2016 | 7 | 2016 |
| Cloning, expression and purification of early secretory antigenic target 6kDa protein (ESAT-6) of Mycobacterium tuberculosis Z Farshadzadeh, M Sankian, F Yousefi, A Gholobi, R Zarif, T Rashed, ... Jundishapur Journal of Microbiology 3 (2), 53, 2010 | 6 | 2010 |
| Cloning and expression of Mycobacterium tuberculosis major secreted protein antigen 85B (Ag85B) in Escherichia coli R Zarif, M Sankian, A Gholubi, Z Farshadzadeh, S Soleimanpour, ... Jundishapur Journal of Microbiology 6 (2), 112-116, 2013 | 5 | 2013 |
| MOLECULAR CLONING, EXPRESSION AND PURIFICATION OF PROTEIN TB10. 4 SECRETED BY MYCOBACTERIUM TUBERCULOSIS A GHOLOUBI, M SANKIAN, R ZARIF, Z FARSHADZADEH, F YOUSEFI, ... IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES 13 (4), 189-193, 2010 | 5 | 2010 |
| Cloning, expression and purification of 10 kd culture filtrared protein (CFP-10) of Mycobacterium tuberculosis F Yousefi, M Sankian, M Moghadam, Z Farshadzadeh, A Gholoubi, R Zarif, ... African Journal of Biotechnology 8 (16), 2009 | 2 | 2009 |
| Determine the inducible resistance phenotype in methicillin resistance staphylococcus aureusand coagulase negative staphylococci YF Naderinasab M, Farshadzadeh Z Iran J Med Microbiol 1 (3), 25-31, 2007 | 1 | 2007 |
| Cloning, expression, purification and the study of immunotherapy status of TGFαL3-SEB chimeric protein in breast cancer treatment F Yousefi, SD Siadat, MM Aslani, AA Imani-Fooladi, O Nasiri, SF Mousavi Journal of Torbat Heydariyeh University of Medical Sciences 6 (3), 13-25, 2018 | | 2018 |
| PROPERTIES OF TGFαL3-SEB FUSION PROTEIN AS A LIGAND TARGETED SUPERANTIGEN IN BREAST TUMOR-BEARING MICE FOLLOWING INTRAVENOUS OR INTRATUMORAL INJECTION F YOUSEFI, SF MOUSAVI, SD SIADAT, FAALI IMANI, MM ASLANI, ... | | 2015 |
| TGFα L3-SEB AS A LIGAND-TARGETED SUPERANTIGEN, DEMONSTRATES POTENT ANTITUMOR ACTIVITIES AGAINST BREAST CANCER XENOGRAFTS F YOUSEFI, SD SIADAT, SA AZIZI, S HESARAKI, MM ASLANI, ... INTERNATIONAL AND IRANIAN CONGRESS OF MICROBIOLOGY 16, 2015 | | 2015 |
| Synthesis and Physicochemical Evaluation of Nanosized Lamivudine Loaded PEGylated Chitosan MRA Hosein Heydari, Mehdi Shafiee Ardestani, Rezvan Zabihollahi, Seyed Mehdi ... Arak Medical University Journal 16 (6), 51, 2013 | | 2013 |
zahra farshadzadehTehran University of Medical SciencesVerified email at razi.tums.ac.ir
